Corthorn J, Valdés G
Centro de Investigaciones Médicas, Santiago, Chile.
Biol Reprod. 1994 Jun;50(6):1261-4. doi: 10.1095/biolreprod50.6.1261.
We have previously demonstrated the presence of tissue kallikrein and its mRNA in rat uterus, and an increase of the immunoreactive enzyme on Day 7 of gestation, which suggests a hormonal regulation and a role in implantation. This study pursued the sequential variations during the cycle and early pregnancy. During the estrous cycle, immunoreactive uterine kallikrein levels showed a recurrent pattern, with the highest value on proestrus (12.9 +/- 1.5 ng/uterus or 0.49 +/- 0.03 ng/mg protein), and the lowest on metestrus (4.1 ng +/- 0.5 ng or 0.30 +/- 0.03 ng/mg protein); p < 0.05. During gestation, values on Day 1 (6.1 +/- 0.4 ng/uterus or 0.30 +/- 0.01 ng/mg protein) and Day 3 (4.9 +/- 0.3 ng or 0.35 +/- 0.01 ng/mg protein) were similar to levels during estrus and diestrus; a progressive rise, observed from Day 5 (8.2 +/- 1.1 ng or 0.43 +/- 0.02 ng/mg protein), attained the highest value on Day 7 (15.8 +/- 1.7 ng or 0.78 +/- 0.05 ng/mg protein); p < 0.05. The variations observed during the cycle and early gestation coincide with those described for ovarian steroids and uterine vasoactive changes, suggest the hormonal regulation of uterine kallikrein levels, and support its role in implantation.
我们之前已证明大鼠子宫中存在组织激肽释放酶及其信使核糖核酸,且在妊娠第7天免疫反应性酶增加,这提示存在激素调节以及其在着床过程中发挥作用。本研究追踪了发情周期和妊娠早期的序列变化。在发情周期中,子宫激肽释放酶免疫反应性水平呈现周期性模式,在动情前期最高(12.9±1.5纳克/子宫或0.49±0.03纳克/毫克蛋白质),在动情后期最低(4.1纳克±0.5纳克或0.30±0.03纳克/毫克蛋白质);p<0.05。在妊娠期间,第1天(6.1±0.4纳克/子宫或0.30±0.01纳克/毫克蛋白质)和第3天(4.9±0.3纳克或0.35±0.01纳克/毫克蛋白质)的值与发情期和动情间期水平相似;从第5天(8.2±1.1纳克或0.43±0.02纳克/毫克蛋白质)开始观察到逐渐上升,在第7天达到最高值(15.8±1.7纳克或0.78±0.05纳克/毫克蛋白质);p<0.05。在发情周期和妊娠早期观察到的变化与卵巢类固醇和子宫血管活性变化所描述的一致,提示子宫激肽释放酶水平受激素调节,并支持其在着床中的作用。